middle.news
Why Is MedAdvisor Selling ANZ and Rethinking Its US Strategy Now?
9:54am on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
Why Is MedAdvisor Selling ANZ and Rethinking Its US Strategy Now?
9:54am on Thursday 31st of July, 2025 AEST
Key Points
Group revenue down 16.6% in 4Q FY25, US revenue falls 34%
ANZ business sold for A$35m upfront plus earn-outs
FY25 revenue guidance downgraded to A$88m with EBITDA loss expected
US strategic options review underway, expected completion by year-end
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MDR
OPEN ARTICLE